Online Trading Starts Here
EN /persons/sun-piaoyang/
AR Arabic
AZ Azerbaijan
CS Czech
DA Danish
DE Deutsche
EL Greek
EN English
ES Spanish
ET Estonian
FI Finnish
FR French
HE Hebrew
HI Hindi
HU Hungarian
IND Indonesian
IT Italian
JA Japan
KK Kazakh
KM Khmer
KO Korean
MS Melayu
NB Norwegian
NL Dutch
PL Polish
PT Portuguese
RO Romanian
... Русский
SV Swedish
TH Thai
TR Turkish
UA Ukrainian
UZ Uzbek
VI Vietnamese
ZH Chinese

Sun Piaoyang Net Worth, Biography and Key Insights

$11.2 B Net worth figures are based on publicly available estimates from sources such as Forbes, Bloomberg, and other reputable financial publications. These values are approximate and may not reflect real-time changes. The data is reviewed and updated biannually. Net worth
236 Data is based on Forbes estimates and may not reflect real-time changes. Information is updated twice a year according to the latest Forbes publications. in the world

Sun Piaoyang’s Profile Summary

Company
Jiangsu Hengrui Medicine Co., Ltd.
Position
Former Chairman and current major shareholder
Source of wealth

Pharmaceuticals

Also known as

Sun Piaoyang

Age
67
Education

China Pharmaceutical University

Citizenship
Chinese
Residence
Jiangsu, China
Family

Married

Website, Social Media
https://www.hrs.com.cn

Sun Piaoyang’s biography

Sun Piaoyang, born in 1958 in China, is one of the most influential figures in the Chinese pharmaceutical industry. He is best known for his leadership at Jiangsu Hengrui Medicine, one of China's largest and most innovative pharmaceutical companies. After earning a degree in chemistry from China Pharmaceutical University, Sun began his career at a state-owned pharmaceutical company. His ambition and vision to transform the Chinese pharmaceutical industry became evident when he took over the leadership of Hengrui in the 1990s.

Under his leadership, Jiangsu Hengrui evolved from a small regional manufacturer into a global pharmaceutical powerhouse. The company became known for its focus on research and development, particularly in the areas of oncology, cardiovascular medicine, and anesthetics. Sun spearheaded Hengrui’s efforts to invest heavily in innovative drug development, moving the company away from generic drug manufacturing and into cutting-edge medical research.

Sun’s efforts paid off, as Hengrui's market value soared, making it one of the most valuable pharmaceutical companies in China. His business acumen and strategic vision have earned him significant recognition in both domestic and international markets. As of recent years, he has stepped down from his day-to-day responsibilities but remains a major shareholder and influential figure in the company’s direction.

  • How did Sun Piaoyang make money?

    Sun Piaoyang's wealth was primarily built through his transformative leadership at Jiangsu Hengrui Medicine. He took over the company in the early 1990s when it was a relatively small regional pharmaceutical manufacturer. Recognizing the potential in China's growing healthcare market, he shifted the company's focus toward innovation and research, specifically in high-demand areas such as oncology and cardiovascular treatments.

    Under Sun’s leadership, Hengrui significantly increased its investment in research and development, which was a strategic decision that set the company apart from other pharmaceutical manufacturers in China. By focusing on innovative drugs rather than generic ones, Hengrui was able to compete with global pharmaceutical giants. The company introduced new, cutting-edge cancer treatments and other life-saving drugs, which greatly boosted its revenues and market share.

    Sun's strategic focus on international expansion further propelled Hengrui’s growth. The company gained approvals from global regulatory bodies such as the U.S. Food and Drug Administration (FDA), allowing it to enter highly lucrative international markets. By the early 2010s, Hengrui had become a leading pharmaceutical company not only in China but also globally, with a strong pipeline of innovative drugs.

    As the largest shareholder of Jiangsu Hengrui Medicine, Sun Piaoyang’s wealth skyrocketed along with the company's valuation. His decision to prioritize innovation and long-term growth over short-term gains has been key to his success. Hengrui’s consistent focus on R&D has made it a leader in China’s biotech sector, and Sun’s legacy in the industry continues to influence its future direction.

  • What is Sun Piaoyang net worth?

    As of 2025, Sun Piaoyang’s net worth is estimated to be $11.2 B.

What is Sun Piaoyang also known as?

Sun Piaoyang is recognized as the former chairman and major shareholder of Jiangsu Hengrui Medicine, one of China's largest pharmaceutical companies. He is widely known for transforming Hengrui into a global leader in medical innovation and oncology drug development.

Prominent achievements of Sun Piaoyang

Sun Piaoyang transformed Jiangsu Hengrui Medicine into China’s most valuable pharmaceutical company. He prioritized R&D investment, leading to the development of groundbreaking drugs in oncology and other critical areas. His efforts have had a lasting impact on the Chinese healthcare industry.

What are Sun Piaoyang’s key insights?

Sun Piaoyang’s business philosophy revolves around long-term innovation and investment in R&D. He believes in creating sustainable value by focusing on high-impact, innovative drugs that address global health challenges.

Sun Piaoyang’s personal life

Sun Piaoyang is married to Zhong Huijuan, a fellow billionaire and the chairwoman of Hansoh Pharmaceutical. The couple has a daughter, Sun Yuan, who is also involved in the family’s business interests.

Useful insights

Fundamental principles of investing

Author, Financial Expert at Traders Union

As someone deeply immersed in the world of finance, I firmly believe that learning the fundamental principles of investing is the cornerstone of financial literacy. The books I recommend here have shaped modern investment strategies, offering timeless wisdom that can benefit both beginners and seasoned investors. These are not just texts, but essential tools to help you navigate the complexities of the financial markets with confidence and insight.

  • Benjamin Graham – "The Intelligent Investor"

    Benjamin Graham – "The Intelligent Investor"
    • Summary:

      Written by one of the most influential investment thinkers, this book outlines the principles of value investing. Graham emphasizes the importance of analyzing a company’s intrinsic value, long-term investment strategies, and avoiding emotional decisions driven by market fluctuations. The book also discusses defensive investing, focusing on preservation of capital and minimizing risk.

    • Why read it:

      This is a must-read for anyone looking to understand the core philosophy behind successful long-term investing. Graham’s principles influenced generations of investors, including Warren Buffett, making it an essential guide to navigating stock market risks with a focus on minimizing losses.

  • Ray Dalio – "Principles"

    Ray Dalio – "Principles"
    • Summary:

      Ray Dalio, founder of one of the world’s largest hedge funds, shares the life and work principles that led to his immense success. The book covers Dalio’s unique management and investment strategies, focusing on radical transparency, truth-seeking, and the importance of learning from mistakes. It also provides practical insights into organizational behavior and personal growth, making it valuable beyond just investing.

    • Why read it:

      Dalio's "Principles" is a treasure trove of wisdom for investors and business leaders who wish to improve their decision-making. It’s a guide on how to align personal and professional life through well-defined, actionable rules.

Popular Financial Guides

Latest Financial News